Omacor Plus Standard Therapies In Post MI Subjects Evaluation: The OPTIMISE Observational Study
Phase of Trial: Phase IV
Latest Information Update: 12 May 2016
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Cardiovascular disorders; Myocardial infarction
- Focus Therapeutic Use
- Acronyms OPTIMISE
- Sponsors Abbott Laboratories
- 22 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Sep 2013 Planned End Date changed from 1 Jun 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov.